298 related articles for article (PubMed ID: 16550749)
1. The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters.
Ulbricht K; Bucha E; Pöschel KA; Stein G; Wolf G; Nowak G
Clin Nephrol; 2006 Mar; 65(3):180-90. PubMed ID: 16550749
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
[TBL] [Abstract][Full Text] [Related]
3. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
[TBL] [Abstract][Full Text] [Related]
4. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
5. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
Naumnik B; Borawski J; Myśliwiec M
Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
7. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
[TBL] [Abstract][Full Text] [Related]
8. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
Demir M; Iqbal O; Untch B; Hoppensteadt DA; Gaikwad BS; Fareed J
Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
Pötzsch B; Hund S; Madlener K; Unkrig C; Müller-Berghaus G
Thromb Res; 1997 Jun; 86(5):373-83. PubMed ID: 9211628
[TBL] [Abstract][Full Text] [Related]
10. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants.
Urlesberger B; Zobel G; Zenz W; Kuttnig-Haim M; Maurer U; Reiterer F; Riccabona M; Dacar D; Gallisti S; Leschnik B; Muntean W
J Pediatr; 1996 Aug; 129(2):264-8. PubMed ID: 8765625
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of hirudin in blood and body fluids.
Nowak G; Bucha E
Semin Thromb Hemost; 1996; 22(2):197-202. PubMed ID: 8807717
[TBL] [Abstract][Full Text] [Related]
13. Effect of anticoagulation on blood membrane interactions during hemodialysis.
Hofbauer R; Moser D; Frass M; Oberbauer R; Kaye AD; Wagner O; Kapiotis S; Druml W
Kidney Int; 1999 Oct; 56(4):1578-83. PubMed ID: 10504511
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of single bolus anticoagulation with enoxaparin for chronic hemodialysis. Results of an open-label post-certification study.
Klingel R; Schwarting A; Lotz J; Eckert M; Hohmann V; Hafner G
Kidney Blood Press Res; 2004; 27(4):211-7. PubMed ID: 15273423
[TBL] [Abstract][Full Text] [Related]
15. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.
Moser M; Ruef J; Peter K; Kohler B; Gulba DC; Paterna N; Nordt T; Kübler W; Bode C
J Thromb Thrombolysis; 2001 Oct; 12(2):165-9. PubMed ID: 11729368
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low-dose heparin in hemodialysis.
Murea M; Russell GB; Daeihagh P; Saran AM; Pandya K; Cabrera M; Burkart JM; Freedman BI
Hemodial Int; 2018 Jan; 22(1):74-81. PubMed ID: 28418614
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.
Sagedal S; Hartmann A; Sundstrøm K; Bjørnsen S; Brosstad F
Nephrol Dial Transplant; 2001 May; 16(5):987-93. PubMed ID: 11328905
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
[TBL] [Abstract][Full Text] [Related]
19. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
20. Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis.
Vanholder RC; Camez AA; Veys NM; Soria J; Mirshahi M; Soria C; Ringoir S
Kidney Int; 1994 Jun; 45(6):1754-9. PubMed ID: 7933823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
